💊 药物 A-Z 🧬 靶点 🛠 工具 📚 指南
全部药物 药物分类 治疗领域 不良反应
指南 术语表 时间轴
药物比较 药物旅程 药物家族
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Levofloxacin

CHEMBL5315124 Phase 4 已批准 Small molecule
Half-Life
6-8 hours
Bioavailability
—
Protein Binding
—
Molecular Weight
361.4 g/mol
LogP
-0.4
Phase
4

A broad-spectrum fluoroquinolone antibiotic used to treat respiratory tract infections, urinary tract infections, skin infections, and certain cases of anthrax. It works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes.

分子量

361.3680 g/mol

LogP

-0.40

TPSA

73.30 Ų

Lipinski 五规则

符合

治疗领域

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Benign Prostatic Hyperplasia Glaucoma Age-Related Macular Degeneration Non-Small Cell Lung Cancer Chronic Obstructive Pulmonary Disease Infectious Disease Stroke Obesity Lymphoma Hypertension Breast Cancer Malaria HIV/AIDS Tuberculosis Heart Failure Prostate Cancer Colorectal Cancer Leukemia

药物分类

J — J - Antiinfectives for Systemic Use

作用机制

Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.

Pharmacokinetics (PK)

Half-Life 6-8 hours

Pharmacodynamics (PD)

机制

Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.

二维结构

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O

                

                

                
                

                    
InChI

                    
InChI=1S/2C18H20FN3O4.H2O/c2*1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h2*7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H2/t2*10-;/m00./s1

                

                

                

                    
                    

                        
Molecular Formula

                        
C18H20FN3O4

                    

                    
                    

                        
HBD / HBA

                        
1 / 8

                    

                    
                    

                        
可旋转键数

                        
2

                    

                    
                    
                    

                        
重原子数

                        
26

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
常见问题

                

                    
                    

                        
                        

                            
A broad-spectrum fluoroquinolone antibiotic used to treat respiratory tract infections, urinary tract infections, skin infections, and certain cases of anthrax. It works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes.

                        

                    

                    

                    

                    
                    

                        
                        

                            
Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.

                        

                    

                    

                    
                    

                        
                        

                            
Key pharmacokinetic parameters for Levofloxacin: Half-life: 6-8 hours.

                        

                    

                    

                    

                        
                        

                            
Yes, Levofloxacin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            
            

                
Related Drugs


                
                

                    
Same Drug Class

                    

                        
                        
                            Amoxicillin
                            Small molecule
                        
                        
                        
                            Azithromycin
                            Small molecule
                        
                        
                        
                            Ciprofloxacin
                            Small molecule
                        
                        
                        
                            Doxycycline
                            Small molecule
                        
                        
                    

                

                

                
            

            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL5315124.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 149096.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.




        


        
        
    


    



    
医疗免责声明

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.